Turkish Journal of Pathology (http://www.turkjpath.org)(ISSN:1018- 5615 / E-ISSN:1309-5730) is the official journal of the Federation of Turkish Pathology Societies and is devoted to the continuing education of national and international practicing pathologists, and to provide a forum for social and scientific communication in the field. The Journal is a peer-reviewed scientific journal published every four months, three times a year (January, May, September), and aims to reach all relevant national and international medical institutions and persons. Articles in English are welcome.
Studies that emphasize these aims provide the basis of publication including original articles, reviews, abstracts from annual meetings, letters to the editor, book reviews, biographies and articles with social content.
Turkish Journal of Pathology accepts only invited review articles.
Case series are evaluated as case reports and are not considered as original articles unless they provide novel results or new techniques/biomarkers/molecular studies/prognostic markers etc. that have not previously been reported. In equivocal situtations, the article type is defined by the editor and their decision is final.
Case reports are evaluated for publication only if they describe a new entity, a new or a very rare histopathological and/or molecular characteristic. Case reports that do not fulfill these criteria will be immediately rejected by editorial decision.
Articles must be in accordance with the “International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (http://www.icmje.org/).
A submitted article must not have been previously published in print or electronic format and must not be under consideration for publication at another journal or electronic media, and, if accepted, must not be published elsewhere in any languages in a similar form. Studies presented at a meeting or symposium or in electronic form will be considered for publication if this is stated.
If any previously published quoted passages, tables, figures, etc. are used in the article, authors should obtain written permission from the publication rights holders and the authors, and should specify this in the article.
Authors are responsible for their articles’ conformity to ethical rules.
All new submissions are screened for plagiarism by similarity check software (Ithenticate).
Turkish Journal of Pathology is a member of Committee of Publication Ethics (COPE) and the position statement of COPE is implemented in our journal (https://publicationethics.org/cope-position-statements/ai-author).
Main rules for use of AI:
1. AI tools cannot be listed as an author of a paper.
2. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent in disclosing in the Materials and Methods (or similar section) of the paper how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.
**Example statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
3. We do not permit the use of Generative AI or AI-assisted tools to create or alter images in submitted manuscripts. This may include enhancing, obscuring, moving, removing, or introducing a specific feature within an image or figure. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original.
THE CONFIDENTIALITY and PRIVACY OF PATIENTS and STUDY PARTICIPANTS
Authors should avoid use of descriptive information such as patient names, initials, reference numbers or full photographs in their manuscript. Such information can be published if absolutely necessary for scientific reasons and only after obtaining written "informed consent" from the patient (or parents, or legal guardian).
For individual case reports, a statement confirming that "informed consent" provided by the patient or a legally authorized representative must be included in the methods section of the manuscript. Authors must also include such a statement in their cover letter. The authors should keep a copy of the written informed consent form and should upload it as a separate file if requested by the Editorial Office.
DECLARATION of CONFLICT of INTERESTS
A conflict of interest is defined as any financial, personal, academically competitive or intellectual relationship between the author, reviewer or editor that involves article submission, referee evaluation, editorial decision and author-referee-editor correspondence and that could lead to a prejudiced and unfair action during the evaluation stage.
Turkish Journal of Pathology requires all authors to acknowledge, on the title page of their manuscript, all funding sources that supported their work, as well as all institutional or corporate affiliations of the authors that might pose a conflict of interest in connection with the submitted manuscript.
The authors must declare any financial relationship or conflict of interest that needs to be known regarding the study. All financial contributions and sponsorships for the study and all financial relationships and conflicts of interest should be included in the title page of the manuscript. The authors must explain the study sponsor’s role in collecting, evaluating and analyzing the data, writing the manuscript and submitting it for publication. If there is no conflict of interest, this section must include a “The authors declare no conflict of interest” statement. All sources of funding should be mentioned in the manuscript.
The evaluation process for the article is not started if a conflict of interest statement is not present at the time the manuscript is submitted. If a conflict of interest becomes apparent after the article is published, the journal may make an official correction or retract the article.
The reviewers also need to declare all their interests that they feel may represent a potential conflict of interest. The reviewers must declare to the editor any conflicts of interest that may prejudice their evaluation of the article and must avoid evaluation of certain articles if a potential prejudice is present.
The editors who will make the final decision on the articles cannot have any personal, professional or financial relationship with any of the authors of the articles they will decide on. The editors will also try to avoid any reviewers who have a possible conflict of interest, for example those working in the same department or facility as any of the authors.
The editors and publisher assume no responsibility regarding features and explanations of any commercial products advertised in the journal.
AUTHORSHIP & CONTRIBUTORSHIP STATEMENT
Every author specified in the manuscript should have properly contributed to the manuscript, should meet the authorship criteria and is responsible for the contributed content. Each section in the manuscript regarding study results and integrity should be the under the responsibility of at least one author. The Turkish Journal of Pathology accepts the criteria of the International Committee of Medical Journal Editors (http://www.icmje.org). The author(s) should accordingly;
For multicenter studies, all declared authors should meet the above authorship criteria. Contribution such as searching for and finding financial support for the study or only collecting data or general help and guidance for those conducting the study do not confer the right to authorship. Individuals who have contributed to the study but do not meet authorship criteria can be included in the “Acknowledgements” section after their consent is obtained. The author order should be the joint decision of all authors. The editor can ask the individual contribution of each author and may find it appropriate to publish this information to prevent an unnecessary increase in the number of authors or unfair academic or similar benefits.
The Turkish Journal of Pathology accepts advertising for products and services that are of interest to users professionally. The decision of acceptance is subject to consultation with the journal’s board of directors. The board of directors reserves the right to accept and reject advertising proposals.
The sources of income of the Turkish Journal of Pathology include institutional support (Federation of the Turkish Pathology Societies) and display advertising for pharmaceutical and nonpharmaceutical products.
RELATIONS WITH EDITOR(S), AUTHOR(S) AND REVIEWER(S)
Editors do not share information regarding articles (manuscript receipt, review process, reviewer opinions or final results) with anyone except authors and reviewers. Reviewers and editorial board members cannot discuss manuscripts in a public manner. Editors must send copies of the manuscript to the editor-in-chief for final decision once their review is complete. Reviews cannot be printed or disclosed without permission of the author and editor. Care is taken to keep the identities of the reviewers confidential. In some cases, the editor may decide to send the reviewer opinions on the manuscript to other reviewers reviewing the same article to inform them during the process. All manuscripts submitted will be subjected to peer review by the editorial board, and the authors will be informed within four weeks. Editorial board reserves the right to make some revisions in the manuscript. Revised manuscripts should also be accompanied by a unique letter with responses to reviewers' comments. Manuscripts that do not comply with the journal requirements listed below may be returned without review at the discretion of the editors. If the journal requests a revision, the author(s) should submit the revised version within three months. Otherwise, it will be considered a new submission.
CHANGES IN AUTHORSHIP
Corresponding author is responsible for accurate declaration of the author list during the initial submission. Changes to the authorship will not be allowed after the acceptance of the manuscript. Exception is only possible if substantial contribution is provided by an additional co-author during manuscript revision process. In such cases, requests to change the authorship, i.e., to include a co-author must be made by sending an official letter to the editorial office that explains the reason for this change request and signed by all authors to show they agree on the change(s), and the new co-author(s). The final decision is made by the editor.
PREPARATION of MANUSCRIPT
Manuscript should be typed in 12 pt (Times New Roman), double spaced throughout with margins of 2.5 cm, and pages must be numbered on the right bottom of the page. Manuscripts must be in accordance with the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/).
Original articles should not exceed 15 double spaced typewritten pages, and case reports should not exceed 10 pages. Articles should be sent in either "doc" or "txt" format and organized as follows:
Figure legends should be included in the main text file after the references.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV- infected patients. N Engl J Med. 2002;347:284-7. PMID: 12140307 DOI: 10.1056/NEJMsb020632
Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. 93-113.
Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.
SUBMISSION OF ARTICLES
All manuscripts must be submitted on-line through the web site (https://turkjpath.org/submit/).
The corresponding author should complete the “Turkish Journal of Pathology Author Responsibility and Copyright Transfer Form” during the submission of manuscript.
Authors will receive a complimentary electronic (PDF) reprint of the article. No hardcopy complimentary reprints are provided by the publisher.
The authors own the copyright for the articles published in Turkish Journal of Pathology. All articles are published as open access under the Creative Commons Attribution License (CC BY). This license means all articles upon publication can be accessed, downloaded, shared, and reused with proper citation.
OPEN ACCESS POLICY
Turkish Journal of Pathology is published as open access under the Creative Commons Attribution License (CC BY). This license means that with the publication all articles can be accessed, shared, downloaded and reused as long as the proper citation is given. Turkish Journal of Pathology adopts the Open Access Declaration published by Budapest Open Access Initiative in Feb, 2002.
Prof. Dr. Volkan ADSAY (Editor-in-Chief)
Koc University, Department of Pathology Istanbul, Turkey
Bulus Design and Printing
Bahriye Ucok Caddesi No: 9/1, Besevler, 06500, Ankara, Turkey
Tel : +90 (312) 223 55 44; +90 (312) 222 44 06
Fax: +90 (312) 222 44 07